Drugs / Detrol LA
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (2) | US (FDA) | DETROL LA | — | 2004-04-14 – 2005-10-20 | fda.gov ↗ |
| Approved | US (FDA) | DETROL LA | — | 2000-12-22 | fda.gov ↗ |
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial · 1 missed | ||||||
| Phase 4 | NCT00282932 | Jan 2006 → May 2007 | overactive bladder | Viatris Inc. | Completed | Missed primary |
| Phase not applicable1 trial | ||||||
| — | NCT00780832 | May 2008 → Dec 2012 | overactive bladder | IWK Health Centre | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Detrol LA | “Detrol LA 4mg. orally, once daily for 30 days” NCT00780832 ↗ |
| Route | Oral | “orally” NCT00780832 ↗ |